Semaglutide in Auto-HSCT

Clinical trial NCT06449625 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06449625
Sponsor: Klaus Gottlob Müller
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Intestinal Mucositis Inflammation Chemotherapeutic Toxicity

Start date: 2024-08-12
Primary completion: 2026-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.